NCT05030649 is a NA clinical trial of Smart glasses in Arterial Line, sponsored by Seoul National University Hospital.

Who is sponsoring NCT05030649?

NCT05030649 is sponsored by Seoul National University Hospital.

What drugs are being tested in NCT05030649?

Interventions in NCT05030649: Smart glasses, Control.

What condition does NCT05030649 study?

NCT05030649 studies Arterial Line.

Is NCT05030649 still recruiting?

NCT05030649 is currently completed. Last updated 7 March 2023.

Last reviewed 2023-03-07 · How we verify

NCT05030649

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Smart-glasses During the Ultrasound-guided Radial Arterial Catheterization in Pediatric Patients by Trainees

Completed NA Last updated 7 March 2023

What this trial tests

NA trial testing Smart glasses in Arterial Line in 122 participants. Completed in 7 February 2023.

Timeline

17 September 2021

Primary endpoint
7 February 2023

7 February 2023

Quick facts

Lead sponsor	Seoul National University Hospital
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	122
Start date	17 September 2021
Primary completion	7 February 2023
Estimated completion	7 February 2023
Sites	1 location across South Korea

Drugs / interventions tested

Smart glasses
Control

Conditions studied

Arterial Line — all drugs for Arterial Line →

Sponsor

Seoul National University Hospital

Who can join

Under 7, any sex, with Arterial Line. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary objective of the study is to evaluate the effect of smart glasses (Head-mounted display Moverio BT-300 (Epson Inc., USA)) on the first-attempt success rate of radial artery cannulation in pediatric patients by less experienced trainees. This study hypothesizes that the use of smart glasses improves the hand-eye coordination and the first-attempt success rate of radial artery cannulation. This is a single-center, randomized, placebo-controlled study comparing the real-time ultrasound image through smart glasses (intervention group) or the ultrasound machine's monitor (control group) during the radial arterial cannulation in pediatric patients undergoing general anesthesia by less experienced trainees.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Effectiveness of head-mounted ultrasound display for radial arterial catheterisation in paediatric patients by anaesthesiology trainees: A randomised clinical trial.
Kim JT, Park JB, Kang P, Ji SH, et al · · 2024 · cited 8× · PMID 38517311 · DOI 10.1097/eja.0000000000001985

Verify or expand the search:

Other trials of Smart glasses

Trials testing the same drug.

NCT04329026 — Smart-glasses During the US-guided Radial Arterial Catheterization in Pediatric Patients: a RCT · NA · completed
NCT03565419 — Use of Smart Glasses for Ultrasound Guided Peripheral Venous Access · NA · completed

Other Seoul National University Hospital trials

Trials by the same sponsor.

NCT07262944 — EOI Block in Otoplasty With Rib Cartilage Graft · NA · recruiting
NCT07464210 — Nemtabrutinib, Bortezomib, and Rituximab for WM · Phase 2 · not yet recruiting
NCT07550803 — Effect of Intraoperative Dexamethasone on Early Postoperative Sleep Quality in Patients Undergoing Nasal Surgery · NA · not yet recruiting
NCT07522138 — Home-based Self-exercise in Patients With Parkinson's Disease: A Feasibility Study · NA · not yet recruiting
NCT07476651 — Scout Dose of Resin Microspheres · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05030649 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Seoul National University Hospital
Last refreshed: 7 March 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05030649.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing